Magnesium deficiency and therapy in cardiac arrhythmias: Recommendations of the German Society for Magnesium Research;Magnesiummangel und Magnesiumtherapie bei Herzrhythmusstörungen: Empfehlungen der Gesellschaft für Magnesium-Forschung e. V.

Deutsche Medizinische Wochenschrift

Volumn 138, Issue 22, 2013, Pages 1165-1171

  Vierling, W ^a   Liebscher, D H ^b   Micke, O ^c   Von Ehrlich, B ^d   Kisters, K ^e,f  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b SHO Mineralimbalancen eV   (Germany)

^c Klinik für Strahlentherapie Am Klinikum Bielefeld   (Germany)

^d Innere Medizin   (Germany)

^e ST ANNA HOSPITAL   (Germany)

^f Institute for Micro Assembly Technology   (Germany)

Author keywords

cardiac arrhythmias; magnesium; prevention; therapeutic recommendation

Indexed keywords

MAGNESIUM;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; HEART ARRHYTHMIA; HUMAN; MAGNESIUM DEFICIENCY; MEDICAL SOCIETY; PARENTERAL NUTRITION; PATIENT MONITORING; PATIENT SAFETY;

ARRHYTHMIAS, CARDIAC; CARDIOLOGY; GERMANY; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; PRACTICE GUIDELINES AS TOPIC;

EID: 84878142402     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0033-1343206     Document Type: Article

References (46)

1. Abdulla W. Interdisziplinäre Intensivmedizin. 3. Aufl. München Elsevier: 2006; 340
2. Antoni D. H., Engel M., Gumpel N. Die Therapie von supraventrikulä ren und ventrikulären Herzrhythmusstörungen mit Magnesium. Mag Bull: 1989; 11 125 129
3. Bailie D. S., Inoue H., Kaseda S. et al. Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs. Circulation: 1988; 77 1395 1402
4. CAST Preliminary Report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med: 1989; 321 406 412
5. Cook R. C., Humphries K. H., Gin K. et al. Prophylactic intravenous magnesium sulphate in addition to oral ß-Blockade does not prevent atrial arrhythmias after coronary artery or valvular heart surgery. Circulation: 2009; 120 163 S169
6. Davey M. J., Teubner D. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med: 2005; 45 347 353 (Pubitemid 43185856)
7. De Oliveira G. S. Jr, Knautz J. S., Sherwani S. et al. Systemic magnesium to reduce postoperative arrhythmias after coronary artery bypass graft surgery: A meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth: 2012; 26 643 650
8. Dichtl A., Vierling W. Inhibition by magnesium of calcium inward current in heart ventricular muscle. Eur J Pharmacol: 1991; 204 243 248
9. Douglas W. W., Rubin R. P. The mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulus-secretion coupling. J Physiol: 1963; 167 288 310
10. Drew B. J., Ackerman M. J., Funk M. et al. Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation. Circulation: 2010; 121 1047 1060
11. Dunning J., Treasure T., Versteegh M. et al. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. Eur J Cardiothorac Surg: 2006; 30 852 872 (Pubitemid 44738601)
12. Fachinformation Sotalex® Sotalex® 160 mg/-mite 80 mg. München, FRG. Bristol-Myers Squibb Stand der Information: Februar: 2010
13. Feyertag J., Laimer H., Herglotz P. et al. Die Wirkung einer oralen Magnesiumsupplementation auf ventrikuläre Arrhythmien und Parameter des Magnesiumstoffwechsels. Mag Bull: 1995; 17 86 90
14. Gu W. J., Wu Z. J., Wang P. F. et al. Intravenous magnesium prevents atrial fibrillation after coronary artery bypass grafting: a meta-analysis of 7 double-blind, placebo-controlled, randomized clinical trials. Trials: 2012; 13 41 48
15. Hall S. K., Fry C. H. Magnesium affects excitation, conduction, and contraction of isolated mammalian cardiac muscle. Am J Physiol: 1992; 263 H622 633
16. Ho K. M., Sheridan D. J., Paterson T. Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis. Heart: 2007; 93 1433 1440 (Pubitemid 351480148)
17. Holzgartner H., Maier E., Vierling W. Hochdosierte orale Magnesiumtherapie bei Herzrhythmusstörungen. Ergebnisse einer Anwendungsbeobachtung bei 1160 Patienten mit Arrhythmie. Fortschr Med: 1990; 108 539 542
18. Iseri L. T. Magnesium and dysrhythmias. Mag Bull: 1986; 8 223 229
19. Iseri L. T. Role of magnesium in cardiac tachyarrhythmias. Am J Cardiol: 1990; 65 47K 50K (Pubitemid 20203293)
20. ISIS-4 A randomised factorial trial assessing early captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet: 1995; 345 669 685
21. Kaseda S., Gilmour R. F. Jr, Zipes D. P. Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibers. Am Heart J: 1989; 118 458 466 (Pubitemid 19222038)
22. Kisters K., Cziborra M., Funke C. et al. Der Magnesiumhaushalt in der Inneren und Intensivmedizin. Nieren- und Hochdruckkrankheiten: 2010; 39 182 194
23. Kisters K., Gröber U. Magnesium Update 2010. DAZ: 2010; 150 2804 2813
24. Kulick D. L., Hong R., Ryzen E. et al. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart J: 1988; 115 367 373 (Pubitemid 18046502)
25. Lewalter T., Lüderitz B. Antiarrhythmika, Magnesium. In: Lüderitz B., Lewalter T. editors. Herzrhythmusstörungen: Diagnostik und Therapie. Vol. 6 Heidelberg Springer: 2010; 125 127
26. Lewis R. V., Tregaskis B., McLay J. et al. Oral magnesium reduces ventricular ectopy in digitalised patients with chronic atrial fibrillation. Eur J Clin Pharmacol: 1990; 38 107 110 (Pubitemid 20097311)
27. Li J., Zhang Q., Zhang M. et al. Intravenous magnesium for acute myocardial infarction. Cochrane Database Syst Rev: 2007; 02 Art. No.: CD002755. DOI: 10.1002/14651858.CD002755.pub2 (Pubitemid 351805826)
28. Liebscher D. H., Baerlocher K., Classen H. G. et al. Magnesiummangel und -therapie bei ADHS. Nieren- und Hochdruckkrankheiten: 2011; 40 123 128
29. Magic Trial Investigators Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet: 2002; 360 1189 1196
30. Manz M., Jung W., Lüderitz B. Einfluss von Magnesium auf anhaltende ventrikuläre Tachkardien. Herz: 1997; 22 01 51 55
31. Manz M., Mletzko R., Jung W. et al. Behandlung von Herzrhythmusstö rungen mit Magnesium. Dtsch Med Wochenschr: 1990; 115 386 390 (Pubitemid 20094728)
32. Mitchell L. B. Canadian cardiovascular society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery. Can J Cardiol: 2011; 27 91 97
33. Onalan O., Crystal E., Daoulah A. et al. Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation. Am J Cardiol: 2007; 99 1726 1732 (Pubitemid 46874321)
34. Shechter M. Does magnesium have a role in the treatment of patients with coronary artery disease? Am J Cardiovasc Drugs: 2003; 3 231 239 (Pubitemid 37074797)
35. Shepherd J., Jones J., Frampton G. K. et al. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation. Health Technol Assess: 2008; 12 iii 95
36. Shimosawa T., Takano K., Ando K. et al. Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings. Hypertension: 2004; 44 897 902 (Pubitemid 39577418)
37. Spätling L., Classen H. G., Külpmann W. R. et al. Diagnostik des Magnesiummangels. Aktuelle Empfehlungen der Gesellschaft für Magnesium-Forschung e. V. MMW Fortschr Med: 2000; 142 49 50 (Pubitemid 30346064)
38. Sueta C. A., Clarke S. W., Dunlap S. H. et al. Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure. Circulation: 1994; 89 660 666 (Pubitemid 24056193)
39. Tong G. M., Rude R. K. Magnesium deficiency in critical illness. J Intensive Care Med: 2005; 20 3 17 (Pubitemid 43093904)
40. Turlapaty P. DMV, Altura B. M. Magnesium deficiency produces spasms of coronary arteries: Relationship to etiology of sudden death ischemic heart disease. Science: 1980; 208 198 200 (Pubitemid 10072143)
41. Tzivoni D., Banai S., Schuger C. et al. Treatment of torsade de pointes with magnesium sulfate. Circulation: 1988; 77 392 397 (Pubitemid 18060048)
42. Vierling W., Ebner F., Reiter M. The opposite effects of magnesium and calcium on the contraction of the guinea-pig ventricular myocardium in dependence on the sodium concentration. Naunyn Schmiedebergs Arch Pharmacol: 1978; 303 111 119 (Pubitemid 8369117)
43. von Ehrlich B., Barbagallo M., Classen H. G. et al. Leitlinie Magnesium und Diabetes. Nieren- und Hochdruckkrankheiten: 2009; 38 633 635
44. Woods K. L., Fletcher S., Roffe C. et al. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet: 1992; 339 1553 1558
45. Zehender M., Meinertz T., Faber T. et al. Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators. J Am Coll Cardiol: 1997; 29 1028 1034 (Pubitemid 27149577)
46. Zipes D. P., Camm A. J., Borggrefe M. et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol: 2006; 48 e247 346 (Pubitemid 44382683)